The Amyotrophic Lateral Sclerosis Als Kurapa Musika aiva USD 0.5372 Bhiriyoni in 2020. Huwandu uhu hunotarisirwa kukwira pamwero wepagore wekukura kwe 5.7% pakati 2020-2029. Musika uyu unofambiswa zvakanyanya nekukura kwehuwandu hwevanhu, kuwedzera kuziva kweALS, uye kuwedzera kwezviitiko. Nekudaro, mutengo wepamusoro wekurapwa kweALS unogona kukanganisa kukura kwemusika panguva yekufanotaura.
Nekuda kwekukwira kwehuwandu hwekufutisa pasi rose, pave kudikanwa kuti paitwe ongororo yakadzama nezvenyaya iyi. Vatyairi vemisika mikuru vari kuwedzera kudya zvakanyanya, kudyiwa kwechikafu, uye kuregeredza maekisesaizi. Chirevo ichi chine rumwe ruzivo nezvezvidzidzo izvi uye chinotarisa pakuwedzera kuri kuda kweAmyotrophic Lateral Sclerosis Treatment (ALS).
Kukura Kudiwa:
North America inotarisirwa kubata musika wakakosha muAmyotrophic Lateral Sclerosis Treatment. Kuwanda kwayo kuri kuwedzera, kudiwa kuri kukura kwemishonga yeALS, kuwedzera kwekushandisa kwehutano, zvivakwa zvakasimbiswa, marongero akanaka ekudzorera, kufambira mberi kwetekinoroji, uye hurongwa hwehutano hwakasimba huchabatsira mukuwedzera kwemusika. Izvi zvinokonzerwa nekuwanda kwezvirwere izvi kune vakwegura. Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry, uye CDC yaona kuti Amyotrophic Lateral Sclerosis Treatment ichabudirira zvikuru mudunhu kana ruzhinji rwuri pamusoro pemakumi mashanu ruchikanganiswa.
Tora muenzaniso weshumo kuti uwane nzwisiso yakazara @ https://market.us/report/amyotrophic-lateral-sclerosis-als-treatment-market/request-sample/
Driving Factors:
Misika yepasi rose amyotrophic lateral sclerosis kurapwa ichafambiswa nekukwira kwehuwandu hwevanhu, kuwedzera kuziva kweALS, uye kuwedzera kwehuwandu hwehuwandu. Vatambi vemusika mumusika weamyotrophic lateral sclerosis kurapwa vanozokwanisa kuita mari mukufambira mberi kwetekinoroji uye kuwedzera ruzivo munzvimbo dziri kusimukira. Musika weamyotrophic lateral sclerosis kurapwa uchamanikidzwa nemitengo yakakwira yekurapwa kweALS uye kushomeka kwenyanzvi dzine hunyanzvi.
.
Musika weamyotrophic-lateral sclerosis kurapwa wakakamurwa kuita kurapwa, nzira yekugovera, uye dunhu. Segmentation yeamyotrophic-lateral sclerosis musika wekurapwa wakagadzirwa kuita stem cell therapy, mushonga, nezvimwe. Zvichangoburwa mvumo yeFDA yakaita kuti chikamu chemishonga ive chikamu chikuru chemusika. Chikamu chekugovera chiteshi chinogona kukamurwa kuita mafemasi echipatara uye ezvitoro zvemishonga. Munguva yekufanotaura, iyo yepamusoro inotarisirwa CAGR iri muchikamu chezvitoro chemishonga.
Restraining Factors:
Musika uyu urikusangana nemitengo yakakwira yekurapwa uye nyanzvi dzepasi-hunyanzvi. Izvi zvinokanganisa kukura kwayo. Kunze kwemutengo wepamusoro, musika hauzive nezvechirwere, uye nzira dzisingashande dzekuongorora dziri kudzikisira kukura kwayo.
Kukura kwemusika kwakadzikira nekushaikwa kwemitemo yekudzosera inopihwa nezvipatara nehurumende yemamiriro euoodegenerative akadai sechirwere cheAlzheimer, chirwere cheParkinson, uye Amyotrophic Lateral Sclerosis (ALS).
Musika Makiyi Trends:
Mishonga yekurapa Amyotrophic Lateral Sclerosis (ALS) inotarisirwa kukura.
Zvinofungidzirwa kuti mishonga inoshandiswa mu amyotrophic-lateral sclerosis kurapwa ichaona kukura kune hutano munguva pfupi. FDA yakabvumidza mishonga miviri yekurapa ALS: riluzole uye edaravone. Iyo FDA yakabvumidzawo NeuRx Diaphragm Pacing System. Inoshandisa maelectrode akaiswa uye mabhatiri kurapa ALS. Pamusoro pezvo, mishonga inogona kubatsira nezviratidzo senge spasticity uye panic attack, pamwe nekurwadziwa nekuora mwoyo. Izvi zvichaguma nekuwedzera kuri kuda kwemishonga yekurapa ALS, zvichitungamira mukukura kwechikamu.
Makambani Makuru:
- Mitsubishi Tanabe Pharma
- Takeda Mishonga
- Sanofi
- Johnson & Johnson
- Nhoroondo yeMylan Pharmaceuticals
- Janssen Pharmaceutical
Segmentation:
mhando
- Riluzole
- Edaravone (Radicava)
kunyoresa
- Chipatara Mishonga
- Retail Pharmacies
- Pamhepo Pharmacies
Inowanzobvunzwa Mibvunzo:
- Ndeipi nguva yekudzidza yemusika uyu?
- Ndeipi mwero wekukura muAmyotrophic Lateral Sclerosis Kurapa Musika?
- Ndeipi dunhu riri kuona kukurumidza kukura muAmyotrophic Lateral Sclerosis Kurapa Musika?
- Ndeipi dunhu rine chikamu chikuru chemusika cheAmyotrophic Lateral Sclerosis Treatment Market?
Ripoti Rinei:
Global Amyotrophic Lateral Sclerosis Drugs Market Chirevo Kuvhara Vepamusoro Key vatambi Boom Drivers & Sales Revenue
Global Amyotrophic Lateral Sclerosis Market Inovhara Vagadziri Vakuru, Vatengesi, Vatengesi 2022-2031
Global Artificial Intelligence muGenomics Market Vatambi Vakakosha vepamusoro (Bhizinesi Strategies & Sales Revenue) Analysis Forecast 2022-2031
About Market.us
Market.US (Inotungamirirwa nePrudour Private Limited) inonyanya kutsvaga nekuongorora kwakadzama. Iyi kambani yanga ichizviratidza seanotungamira kubvunza uye akagadziridzwa musika muongorori uye anoremekedzwa zvakanyanya-anoremekedzwa akabatanidzwa-anoremekedzwa musika wekutsvaga mushumo wekupa.
Mashoko Okukurukura:
Global Business Development Team - Market.us
Market.us (Inofambiswa nePrudour Pvt. Ltd.)
Kero: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States
Runhare: +1 718 618 4351 (Kunyika Dzepasi Pose), Runhare: +91 78878 22626 (Asia)
Email: [email inodzivirirwa]
ZVOKUBVA MUNYAYA INO:
- The Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry, and CDC have determined that Amyotrophic Lateral Sclerosis Treatment will be more successful in the region if the majority over 50 is affected.
- Market players in the amyotrophic lateral sclerosis treatment market will be able to capitalize on technological advances and increase awareness in developing areas.
- The market’s growth has been slowed by a lack of reimbursement policies offered by hospitals and the government for neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis (ALS).
